Passionate about biotechnology & the new drugs developers, I am focus to identify WIN-WIN synergies between your molecule journey and our technologies/offers. - Strong scientific background with over 18 years of biotechnology industry experience in CDMO operations: R&D, process development and GMP production - mAb & no mAb proteins - Team management - Project Management - Partner oriented to bring the best strategy according to budget and timeline constraints At Just Evotec Biologics, we design and apply innovative technologies to dramatically expand global access to biotherapeutics. Our integrated continuous manufacturing platforms operate within cGMP facilities that employ autonomous clean room technology for the cost-efficient production of antibodies, next-generation biologics and biosimilar products. Our key offers: 🔬J.Discovery™ Services: Offers identification and validation of antibody therapeutics with superior developability, powered by our humanoid antibody library J.HALSM 🎯J.MD™ Molecular Design Suite: Our state-of-the-art suite has a proven record in antibody developability optimization, improving stability and expression for instance, ensuring smooth transition and progress through clinical stages First In Human (DNA to IND) in 12 months with our proprietary cell line 💲Cost Optimization: Just-Evotec Biologics has achieved a remarkable reduction in COGM (Cost of Goods Manufactured) with our continuous biomanufacturing platform —as low as $50 per gram. ⭐Platform validation: Our recent partnership with Sandoz  and the U.S. Department of Defence  serves as validation for our ground-breaking platform. At Just – Evotec Biologics, collaboration and innovation are at the heart of everything we do. We also understand that biotherapeutics development is a unique journey and that's why we offer partnership opportunities at every step of the development phase – from discovery to market supply. While we offer traditional CDMO fee-for-service approaches, our commitment to strategic partnership runs deep. We are always open to evaluate co-development, integrated programs and technology out-licensing opportunities.